PharmaShots | Incisive News in 3 Shots

Subscribe Now

polivy

$Chugai's Polivy Receives MHLW's Approval for Relapsed or Refractory Diffuse Large B-cell Lymphoma$

Chugai's Polivy Receives MHLW's Approval for Relapsed or Refractory Diffuse Large B-cell Lymphoma

March 25, 2021

Roche's Polivy (polatuzumab vedotin) Receives Health Canada's Approval For R/R Diffuse Large B Cell Lymphoma

Roche's Polivy (polatuzumab vedotin) Receives Health Canada's Approval For R/R Diffuse Large B Cell Lymphoma

September 25, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us